intravenous glutathione parkinson& 39 Ferroptosis in Parkinson's disease: glia–neuron crosstalk: Trends in Molecular Medicine The glutathione system in Parkinson's

Although considerable progress has been achieved in detecting common driver mutations (such as EGFR, ALK and ROS1), there is an urgent need for more sensitive and comprehensive biomarker platforms capable of detecting rare mutations, gene fusions and intricate molecular profiles (306308)

A lot of evidence has shown that excessive activation of NMDARs in AD is related to changes in the expression of calpain, Ca 2+ /CaMKII, GSK-3, and other proteins, which play crucial roles in excitotoxicity and neurodegeneration [151]

Its a catastrophic point of failure that is, thankfully, entirely avoidable

Vitamin B12s half-life in plasma is approximately six days, whereas in the liver, it's approximately one year (7)

Visible results in just 12 weeks